Neogen Chemicals Limited sees a credit rating action

The latest CRISIL rationale attributes the outlook revision to a materially stronger financial risk profile after Neogen’s Rs 600-crore QIP, with proceeds earmarked for debt reduction and working-capital needs. This was expected to reduce reliance on external borrowings and improve financial flexibility. ^[1]

However, the before-and-after debt-to-EBITDA and interest-coverage ratio figures are not stated in the rating-rationale extract available here. Therefore, the precise ratio improvement cannot be reported reliably without the full CRISIL rationale. The ratios would be on CRISIL’s consolidated analytical basis, which includes Neogen Chemicals, Neogen Ionics and other specified entities; CRISIL also treated Rs 59.2 crore of unsecured loans as debt as of March 31, 2026. ^[1]

Verdict: The revised outlook is supported by a shift away from incremental short-term borrowing, but it does not eliminate refinancing risk. Neogen’s debt is currently weighted toward non-current borrowings, while the ₹600 crore QIP provides equity capital for debt reduction and working capital. However, ongoing battery-chemicals capex remains materially debt-funded, so long-term debt will continue to be important and the FY28 NCD maturity remains a key funding event.

Debt maturity and instrument mix

• On the consolidated FY26 balance sheet, current borrowings were Rs 510.74 Cr and non-current borrowings were Rs 819.15 Cr, against total debt of approximately Rs 1,329.9 Cr. This equates to roughly 38.40% current and 61.60% non-current borrowings, derived from the reported balances. ^{[2] [3] [4]}
• The disclosed maturity profile includes moderate repayments of Rs 60-75 Cr over the medium term, excluding a Rs 200 Cr non-convertible debenture repayment in FY28. ^[5]
• The short-term rating was reaffirmed at CRISIL A2+, while NCL’s long-term rating was reaffirmed at CRISIL A- with a Stable outlook. The rating action therefore does not signal a deterioration in access to short-term working-capital facilities, but it also does not imply that short-term instruments are the primary funding source. ^[6]

How capex is being funded

• The battery-chemicals capex was estimated to be debt-funded to the extent of Rs 1,143 Cr, with completion expected in Q4 FY27. ^[5]
• The completed Rs 600 Cr QIP changes that mix by adding equity funding. CRISIL specifically stated that the proceeds are intended for debt reduction and working-capital requirements, lowering reliance on external borrowing. ^[6]
• Liquidity is also expected to be supported by internal cash accruals, insurance receivables and unutilised bank lines; promoter unsecured funding of Rs 59.2 Cr as of March 31, 2026 was cited as an additional flexibility measure. ^[5]

Implication: The Stable outlook reflects improved balance-sheet flexibility from equity injection and a manageable scheduled repayment burden, rather than a fully de-levered capex plan. The funding structure still relies more on long-term debt for project financing than on short-term instruments, while short-term facilities remain relevant for working capital. The main monitorables are the application of QIP proceeds to debt reduction, timely commissioning of the battery projects, and the refinancing or repayment of the Rs 200 Cr NCD in FY28.

The rating disclosure does not provide a complete instrument-by-instrument maturity ladder. Therefore, the 38.40% current versus 61.60% non-current split should be treated as a balance-sheet classification, not a precise contractual maturity schedule.

CRISIL kept Neogen Ionics Limited (NIL) one rating notch below Neogen Chemicals Limited (NCL): NCL was reaffirmed at CRISIL A-/Stable with CRISIL A2+ short-term rating, while NIL was reaffirmed at CRISIL BBB+/Stable. ^[6]

How CRISIL differentiates NIL from NCL

• NIL carries the weaker underlying credit profile. It is still building its battery-chemicals business, with exposure to the timely implementation and completion of its manufacturing project and an average financial risk profile. CRISIL’s FY26 data showed NIL operating income of Rs 36.66 Crores and a reported loss of Rs 17.85 Crores. ^[7]
• NCL benefits from the stronger group-level financial position. The Rs 600 Crores QIP improved the net-worth base and capital structure, with proceeds intended for debt reduction and working-capital requirements. This was the principal reason for moving the outlook from Negative to Stable. ^[6]
• The comparison is not strictly “NIL standalone versus NCL standalone.” CRISIL’s NCL rationale consolidated NCL with NIL and other group entities, whereas NIL received a separate rating that explicitly incorporated expected parent support. Therefore, NCL’s A-/Stable rating reflects the consolidated group risk profile rather than a pure standalone-parent assessment. ^[5]

Support mechanisms incorporated by CRISIL

CRISIL applied its parent-support and notch-up framework to NIL because:

• NCL owns 100% of NIL, creating a strong strategic and financial linkage. ^[8]
• CRISIL factored in business, managerial and financial/distress support from NCL. ^[8]
• The agency expected NCL to provide operational and managerial support and, in a stress situation, distress support to enable NIL to meet its debt obligations on time. ^[7]
• NCL had extended corporate guarantees for NIL’s debt obligations, which was a specific credit-enhancement factor in NIL’s rating assessment. ^[8]

The key distinction is that NIL’s BBB+/Stable rating still reflects its weaker project-stage operating and financial risk; the parent guarantee and expected support prevent that risk from translating into a rating detached from the group, but they do not make NIL credit-equivalent to NCL. The current filing does not quantify the guarantees or identify a new guarantee as the direct trigger for Stable; the explicit trigger was the QIP-led improvement in group financial flexibility. ^[6]